InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Gall Matthew. Director active across 2 companies, notably iTeos Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Total volume traded: €628k. The latest transaction was filed on 27 December 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€205,0915,000 shares@ €41.018152.5% of flow
Common Stock
SEC:0001209191-21-071435·
€205,0915,000 shares@ €41.018126.2% of flow
Common Stock
SEC:0001209191-21-071435:0·
€76,93014,429 shares@ €5.331619.7% of flow
Common Stock
SEC:0001209191-21-060297·
€76,93014,429 shares@ €5.33169.8% of flow
Common Stock
SEC:0001209191-21-060297:0·
€108,7455,000 shares@ €21.749127.8% of flow
Common Stock
SEC:0000899243-21-024236·
Ideal exit: 13 Mar 2022 (T+270)
€108,7455,000 shares@ €21.749113.9% of flow
Common Stock
SEC:0000899243-21-024236:0·
Ideal exit: 13 Mar 2022 (T+270)
6 of 6 declarations
About Gall Matthew
Matthew Gall is a director at iTeos Therapeutics, Inc.
